ASSESS

ASSESS has been established to re-think how life sciences technology innovators and academic technology transfer offices are supported with early value assessment. ASSESS connects those with expertise in health technology assessment (HTA) and health economic modelling with those that require insights from these disciplines to maximize technology commercial opportunity Specifically ASSESS provides the following: Early Health Technology Assessment (eHTA): ASSESS connects innovators developing health technologies with experts who provide an early health technology assessment. This helps determine the commercial potential and evidence requirements needed to bring the product to market. Strategic Decision Support: ASSESS supports innovators in making foundational strategic decisions. This includes focusing research and development, commercialization, and evidence generation efforts on high-value areas from the perspective of payers and end users. Value Assessment and Health Economic Analysis: ASSESS helps innovators with early value assessment and health economic analysis. This quantifies the Adoption Case for technology in development, aiding investors in understanding the commercial potential, attractiveness to payers, and pricing power. Trial Case Support: ASSESS assists innovators in making the trial case for technology in development. This involves helping health systems understand the problem the technology aims to solve and structuring trials to assess the technology's economic impact. Procurement Case Articulation: ASSESS supports innovators in articulating the procurement case for market-ready technology. This includes using robust health economic modelling and trial data analysis to quantify the technology's value and budget impact, and providing guidance on additional evidence collection if needed.